跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,095 条关于
“SVN-SDN-014”
全部
6,095
临床试验
2,756
药物
2,686
机构
157
资讯
496
去年
Solvonis Therapeutics Launches AI-Powered CNS Drug Discovery Platform for Depression and Addiction
8个月前
Solvonis Therapeutics' SVN-15 Matches Prozac Efficacy in Depression Model, Targets Dual Serotonin-Dopamine Pathway
11个月前
LEAP-014 Trial Shows Lenvatinib Triple Combination Fails to Improve Survival in Metastatic Esophageal Cancer
去年
Foresee Pharmaceuticals to Present Phase 3 KATANA Studies of Novel Prostate Cancer Treatment at ASCO-GU 2025
去年
Solvonis Therapeutics Raises £1M to Accelerate AI-Driven CNS Drug Discovery for Depression and Stimulant Addiction
去年
Rege Nephro Secures $150 Million in Series B Funding to Advance Kidney Disease Therapies
去年
Redica Systems Secures New Financing to Enhance AI-Driven Quality Intelligence in Life Sciences
去年
Rege Nephro Acquires Tamibarotene Assets from Syros Pharmaceuticals for ADPKD Development
去年
Malaysia Extends Biocon Biologics' Insulin Supply Contract for Six Additional Months
2个月前
Biocon and Duopharma Biotech Secure Over MYR 225 Million in Insulin Contracts from Malaysia's Ministry of Health
第 1 页,共 50 页
上一页
下一页